EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Pain and Sedative Medication Use Among Individuals With Inflammatory Bowel Disease: A Nationwide Population‐Based Cohort Study

Samantha Baillie iD, Sonia Saxena iD, Nishani Jayasooriya iD, Alex Bottle, Irene Petersen, Jonathan Blackwell, Richard Pollok iD

Alimentary Pharmacology & Therapeutics · 2025

DOI: 10.1111/apt.70247 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2025. Verfasst von Samantha Baillie und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Infection and Immunity, City St George's University of London, London, UK. Hauptthemen laut MEDLINE: Hypnotics and Sedatives, Inflammatory Bowel Diseases, Analgesics, Opioid, Pain. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research (NIHR) School for Public Health Research (SPHR), School for Public Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Individuals with inflammatory bowel disease (IBD) often experience pain, mood disturbances, and sleep disruption, which may lead to greater use of pain‐relieving and sedative medications compared with the general population. These are associated with increased mortality, paradoxical worsening of pain, and inappropriate IBD treatment discontinuation. Chronic prescribing and co‐prescribing increase the risk of respiratory depression, dependence, and overdose.

Methods

Using Clinical Practice Research Datalink, a large nationally representative dataset, we examined the annual prevalence of total, chronic (> 90 days opioids; > 28 days sedatives), and co‐prescribed opioids, gabapentinoids and sedatives in adults with incident IBD from January 2010 to December 2019. Multivariable regression identified predictors of chronic or co‐prescribing.

Results

Among 17,388 individuals, over 20% were prescribed a pain or sedative medication each year. Annual prevalence for opioids and gabapentinoids increased (13.6%–14% and 2.5%–5.6%, respectively) while sedative prevalence remained stable (8.4%). Chronic prescribing increased for strong opioids (3.6%–4.6%), weak opioids (3.6%–3.7%) and sedatives (4.2%–4.4%). Between 4.2% and 6.9% of individuals per year were co‐prescribed opioids, gabapentinoids, and/or sedatives. Female sex, smoking, older age at diagnosis, Crohn's disease, and a diagnosis of inflammatory arthropathy, irritable bowel syndrome, fibromyalgia, or anxiety/depression were significantly associated with chronic and/or co‐prescriptions of opioids or sedatives.

Conclusion

A substantial proportion of individuals with IBD are prescribed pain and sedative medications, including long‐term and co‐prescriptions. Identifying high‐risk patients is essential to ensure they are prioritised for limited resources, such as psychological therapies, as alternatives to harmful prescriptions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypnotics and SedativesInflammatory Bowel DiseasesAnalgesics, OpioidPainPractice Patterns, Physicians'HumansFemaleMaleAdultMiddle AgedCohort StudiesYoung AdultAgedAdolescentGabapentin

Stichwörter der Autor:innen

Crohn's diseaseabdominal painepidemiologygeneral practiceguidelinesinflammatory bowel diseaseulcerative colitis

Substanzen

Hypnotics and SedativesAnalgesics, OpioidGabapentin

Autor:innen und Institutionen

  • Institute for Infection and Immunity, City St George's University of London, London, UK.
  • School of Public Health, Imperial College London, London, UK.
  • Research Department of Primary Care and Population Health, University College London, London, UK.
  • Edinburgh Inflammatory Bowel Disease Unit, Western General Hospital, Edinburgh, UK.
  • Department of Gastroenterology, St George's University Hospitals NHS Foundation Trust, London, UK.

ORCID-Profile: Samantha Baillie, Sonia Saxena, Nishani Jayasooriya, Richard Pollok

Förderung

  • National Institute for Health and Care Research (NIHR) School for Public Health Research (SPHR)
  • School for Public Health Research

Zitieren

APA

Baillie, S., Saxena, S., Jayasooriya, N., Bottle, A., Petersen, I., Blackwell, J., & Pollok, R. (2025). Pain and Sedative Medication Use Among Individuals With Inflammatory Bowel Disease: A Nationwide Population‐Based Cohort Study. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70247

Vancouver

Baillie S, Saxena S, Jayasooriya N, Bottle A, Petersen I, Blackwell J, et al. Pain and Sedative Medication Use Among Individuals With Inflammatory Bowel Disease: A Nationwide Population‐Based Cohort Study. Alimentary Pharmacology & Therapeutics. 2025. doi:10.1111/apt.70247

BibTeX
@article{Baillie2025,
  author = {Baillie, Samantha and Saxena, Sonia and Jayasooriya, Nishani and Bottle, Alex and Petersen, Irene and Blackwell, Jonathan and Pollok, Richard},
  title = {Pain and Sedative Medication Use Among Individuals With Inflammatory Bowel Disease: A Nationwide Population‐Based Cohort Study},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2025},
  doi = {10.1111/apt.70247}
}
Kostenlos starten →